Elgi Equipments Ltd

- No specific mention of any current or planned fundraising through debt or equity in the transcript. - The company’s debt increased by Rs. 65 Crores due to inventory buildup, not due to new borrowing plans. - Total capex spend so far is about Rs. 25 Crores with an expected additional Rs. 25-30 Crores for the remaining year; no large capex-related fundraising indicated. - There is a major capex plan to shift city operations to a main campus outside the city, but details on numbers and timing are yet to be shared. - No statements about issuing new equity or raising large debt recently or in near future from the provided transcript.

- Total capex spend so far in the current year is about Rs. 25 Crores, with an expected additional Rs. 25 to 30 Crores for the remainder of the year; nothing significant planned beyond this. - A major capex plan is underway to shift city operations to the main campus outside the city; details on costs and timing will be shared once finalized. - No capex investment from the parent company into the subsidiary ELGi Sauer; any capex there is handled by the subsidiary itself. - Investment in new machinery for motor production faced delays; canceled order with one vendor, switched to another with machine delivery expected by Q4 of the financial year, aiming for full motor plant capacity stabilization next year. - Capacity expansion and global expansion efforts are ongoing with focus on revenue-driven margin improvements rather than margin extraction.

- Q3 outlook is cautiously optimistic: first two months show continued growth momentum similar to Q2, but uncertainty remains beyond November (Page 17). - Domestic volume growth without oxygen compressors was about 8%; consolidated volume growth (excluding oxygen) is ~18% (Page 13, 16). - Positive growth seen across most industry verticals except textiles, though conversion of inquiries to orders is uncertain (Page 14). - European expansion ongoing with breakeven now expected in FY2025 instead of FY2024 due to COVID delays; growth prioritized over margin extraction (Page 14, 16). - Price realization improved after corrections, supporting margins despite earlier cost volatility (Page 7). - Growth driven by global expansion, competitive lead times, and increased inquiries, but cautious about global macroeconomic risks like inflation and recession (Pages 4, 6, 13).

- Q3 outlook: Growth momentum continues with topline steady in first two months, though not exceeding Q2; cautious beyond Q3 due to possible market unpredictability (Page 17). - Margins: 16% operating margin target set for 2025-2026; current margins around 14.5%. Growth prioritized over margin extraction (Page 14). - Europe expansion: Break-even now expected FY2025 (delayed from FY2024 due to COVID); losses lower than planned; better-than-expected performance (Page 10). - Pricing: Past price increases have stuck across geographies, supporting gross margins (Page 15-16). - Volume growth: Consolidated volume growth approx. 8% excluding oxygen compressors; India volume growth positive but outlook uncertain due to macro factors (Page 6, 13). - Focus on profitable growth: Operating profit improvements expected mainly through volume growth rather than margin expansion (Page 10).

The transcript on the provided pages does not specifically mention the current or expected order book or pending orders for ELGi Equipments Limited. The discussion primarily focuses on: - Quarterly financial performance and EBITDA analysis. - Growth outlook in domestic and international markets. - Impact of oxygen concentrators on sales. - Pricing strategies and competition. - Status of backward integration and motor production delays. - European market expansion and its planned breakeven timeline. - Inventory increase due to supply chain and lead time uncertainties. No explicit details or figures regarding the order book or pending orders were disclosed during this call.